{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:41:12Z","timestamp":1740148872829,"version":"3.37.3"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13071-018-3170-4","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T03:52:37Z","timestamp":1542599557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety of topical administration of fluralaner plus moxidectin concurrently with praziquantel in cats"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6927-9802","authenticated-orcid":false,"given":"Feli M.","family":"Walther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Fisara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer K. A.","family":"Roepke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"key":"3170_CR1","volume-title":"Community register of veterinary medicinal products, Product information, Annex 1 Summary of product characteristics Bravecto Plus spot-on solution for cats","author":"European Commission","year":"2018","unstructured":"European Commission. Community register of veterinary medicinal products, Product information, Annex 1 Summary of product characteristics Bravecto Plus spot-on solution for cats. 2018. \n                    http:\/\/ec.europa.eu\/health\/documents\/community-register\/2018\/20180508140629\/anx_140629_en.pdf\n                    \n                  . Accessed 25 Jun 2018."},{"key":"3170_CR2","volume-title":"Community register of veterinary medicinal products, Product information, Annex 1 Summary of product characteristics Bravecto spot-on solution for cats","author":"European Commission","year":"2018","unstructured":"European Commission. Community register of veterinary medicinal products, Product information, Annex 1 Summary of product characteristics Bravecto spot-on solution for cats. 2018. \n                    http:\/\/ec.europa.eu\/health\/documents\/community-register\/2018\/20180319140371\/anx_140371_en.pdf\n                    \n                  . Accessed 22 Aug 2018."},{"key":"3170_CR3","doi-asserted-by":"crossref","unstructured":"Rohdich N, Zschiesche E, Wolf O, Loehlein W, Pobel T, Gil MJ, et al. Field effectiveness and safety of fluralaner plus moxidectin (Bravecto\u00ae Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats. Parasit Vectors. 2018 (In Press).","DOI":"10.1186\/s13071-018-3175-z"},{"key":"3170_CR4","doi-asserted-by":"crossref","unstructured":"Rohdich N, Zschiesche E, Wolf O, Loehlein W, Kirkova Z, Iliev P, et al. A randomized, blinded, controlled, multi-centered field study assessing the treatment of nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto\u00ae Plus). Parasit Vectors. 2018 (In Press).","DOI":"10.1186\/s13071-018-3169-x"},{"key":"3170_CR5","volume-title":"Summary of product characteristics Droncit Spot-on 20 mg Solution","author":"Department for Environment Food & Rural Affairs, Veterinary Medicines Directorate","year":"2017","unstructured":"Department for Environment Food & Rural Affairs, Veterinary Medicines Directorate. Summary of product characteristics Droncit Spot-on 20 mg Solution. 2017. \n                    http:\/\/www.vmd.defra.gov.uk\/productinformationdatabase\/SPC_Documents\/SPC_137995.DOC\n                    \n                  . Accessed 25 Jun 2018."},{"key":"3170_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s13071-016-1618-y","volume":"9","author":"FM Walther","year":"2016","unstructured":"Walther FM, Allan MJ, Roepke RKA. Safety of concurrent treatment of cats with fluralaner and emodepside-praziquantel. Parasit Vectors. 2016;9:322.","journal-title":"Parasit Vectors."}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-3170-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-018-3170-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-3170-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T19:27:27Z","timestamp":1574105247000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-018-3170-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3170"],"URL":"https:\/\/doi.org\/10.1186\/s13071-018-3170-4","relation":{},"ISSN":["1756-3305"],"issn-type":[{"type":"electronic","value":"1756-3305"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"assertion":[{"value":"11 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in 2017 in Queensland, Australia, under the Australian Pesticides and Veterinary Medicines Authority (APVMA) General Permit PER7250 covering a defined range of Small Scale Trials.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FMW is an employee of Merck Animal Health, Madison, NJ, USA; PF and RKAR are employees of MSD Animal Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"597"}}